Cole Brown’s confidence might have been a little down after his last two outings. His team’s confidence might have been just as low after its performance in the first game of last Wednesday’s ...

It’s been a nice season thus far for the Post 32 Beckley Top Prospects. On Tuesday, they’ll be playing to extend it. Beckley will close its regular season at home against Clendenin Post 61 at Linda K.

A Raleigh County man is behind bars with no bond after being charged with first-degree murder in the shooting death of his ...

BECKLEY – A Raleigh County man was sentenced Wednesday for his role in a drug trafficking organization, according to a press release from the U.S. Attorney’s Office for the Southern ...

South Korean electronics giant Samsung has continued a push into the health category with an agreement to buy Xealth, a ...

Conference Call atai and Beckley Psytech will host a conference call and live webcast today Tuesday, July 1, 2025, 2025 at 8:00 a.m. EDT.

Beckley’s mebufotenin showed a difference of 5.3 points and 6.3 points for the two therapeutic doses it tested as compared with a low-dose group used as a control when measured at Day 29 after ...

BPL-003 is Beckley Psytech’s patent-protected, proprietary intranasal formulation of mebufotenin benzoate, administered via a nasal spray device used in a previously approved drug product.

BECKLEY — A U.S. District Court judge has sentenced a 25-year-old Beckley man to four months in prison for escaping from a federal facility. Kishaun Andre Jones, 25, of Beckley, was sentenced ...

Beckley Psytech’s psychedelic drug has successfully reduced the symptoms of depression in a phase 2 study, triggering the next stage of a planned merger with mental health-focused company Atai ...

Cosmo Feilding Mellen, Chief Executive Officer and Co-Founder of Beckley Psytech, said: "The achievement of our primary and secondary endpoints in this study represents an important milestone in the ...

In a Phase 2b clinical trial, Beckley’s compound, BPL-003 — an intranasal formulation of mebufotenin, a short-acting compound related to the psychedelic DMT — led to a reduction of 12.1 and ...